Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gero Massenkeil

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
World Journal of Urology|February 3, 2005
Nonmyeloablative allogeneic stem cell transplantation in metastatic renal cell carcinoma: a new therapeutic option or just a clinical experiment?Jan Roigas, Gero Massenkeil
Medizinische Klinik (Munich, Germany : 1983)|February 27, 2007
[Liver cirrhosis]Thorsten Brechmann, Gero Massenkeil, Wolff Schmiegel
FEBS Letters|February 28, 2003
Concurrent increase of cholesterol, sphingomyelin and glucosylceramide in the spleen from non-neurologic Niemann-Pick type C patients but also patients possibly affected with other lipid trafficking disordersKlaus Harzer, Gero Massenkeil, Eckhart Fröhlich
Expert Review of Anticancer Therapy|October 31, 2006
Allogeneic stem cell transplantation for patients with metastatic renal cell carcinomaJan Roigas, Manfred Johannsen, Martin Ringsdorf, et al.
World Journal of Gastroenterology|November 18, 2014
Cirrhotic cardiomyopathy: a cardiologist's perspectiveNatig Gassanov, Evren Caglayan, Nasser Semmo, et al.
Electrophoresis|June 30, 2006
Evaluation of whole-genome amplification of low-copy-number DNA in chimerism analysis after allogeneic stem cell transplantation using STR marker typingMarion Nagy, Jelena Rascon, Gero Massenkeil, et al.
Oral Oncology|February 20, 2008
Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignanciesThacharot Boonyapakorn, Ingrid Schirmer, Peter A Reichart, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 28, 2004
Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHDGero Massenkeil, Marion Nagy, Philipp Le Coutre, et al.
Journal of the American Society of Nephrology : JASN|September 29, 2006
Major histocompatibility complex HLA region largely explains the genetic variance exercised on neutrophil membrane proteinase 3 expressionSibylle von Vietinghoff, Andreas Busjahn, Constanze Schönemann, et al.
European Journal of Haematology|January 27, 2011
A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplantsPhilipp G Hemmati, Theis H Terwey, Philipp le Coutre, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
World Journal of Urology|February 3, 2005
Nonmyeloablative allogeneic stem cell transplantation in metastatic renal cell carcinoma: a new therapeutic option or just a clinical experiment?Jan Roigas, Gero Massenkeil
Medizinische Klinik (Munich, Germany : 1983)|February 27, 2007
[Liver cirrhosis]Thorsten Brechmann, Gero Massenkeil, Wolff Schmiegel
FEBS Letters|February 28, 2003
Concurrent increase of cholesterol, sphingomyelin and glucosylceramide in the spleen from non-neurologic Niemann-Pick type C patients but also patients possibly affected with other lipid trafficking disordersKlaus Harzer, Gero Massenkeil, Eckhart Fröhlich
Expert Review of Anticancer Therapy|October 31, 2006
Allogeneic stem cell transplantation for patients with metastatic renal cell carcinomaJan Roigas, Manfred Johannsen, Martin Ringsdorf, et al.
World Journal of Gastroenterology|November 18, 2014
Cirrhotic cardiomyopathy: a cardiologist's perspectiveNatig Gassanov, Evren Caglayan, Nasser Semmo, et al.
Electrophoresis|June 30, 2006
Evaluation of whole-genome amplification of low-copy-number DNA in chimerism analysis after allogeneic stem cell transplantation using STR marker typingMarion Nagy, Jelena Rascon, Gero Massenkeil, et al.
Oral Oncology|February 20, 2008
Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignanciesThacharot Boonyapakorn, Ingrid Schirmer, Peter A Reichart, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|September 28, 2004
Nonmyeloablative stem cell transplantation in patients with ALL and AML results in low nonrelapse mortality despite high rate of infections and GVHDGero Massenkeil, Marion Nagy, Philipp Le Coutre, et al.
Journal of the American Society of Nephrology : JASN|September 29, 2006
Major histocompatibility complex HLA region largely explains the genetic variance exercised on neutrophil membrane proteinase 3 expressionSibylle von Vietinghoff, Andreas Busjahn, Constanze Schönemann, et al.
European Journal of Haematology|January 27, 2011
A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplantsPhilipp G Hemmati, Theis H Terwey, Philipp le Coutre, et al.
Pageof 2